Zimmer Biomet Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Coming to you live from the Morgan Stanley Healthcare Conference Year 2020. My name is David Lewis, medical device analyst at Morgan Stanley. And thanks for joining us here as we progress through the afternoon. It's our pleasure to have with us here members of management of Zimmer Biomet, both Bryan Hanson, CEO; and Suky Upadhyay, the CFO; and Keri is here as well. We're going to jump right into Q&A.
Questions & Answers
Bryan, I think we're going to dispense with the preamble. And I want to start, Bryan, just on recovery here with COVID-19. We had a pretty bullish intraquarter here post the second quarter.
Just want to kind of talk about a little bit about what has happened from a trend line perspective here in July, August and into September?
Yes. So can you hear me okay?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |